Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 4/20 | 0.57 |
| ▸ | MMP9 | P14780 | 2/20 | 0.57 |
| ▸ | PLAU | P00749 | 4/20 | 0.47 |
| ▸ | HPN | P05981 | 4/20 | 0.47 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.46 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.44 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | MMP13 | P45452 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | MMP1 | P03956 | 1/20 | 0.42 |
| ▸ | MMP8 | P22894 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MMP3 | P08254 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL200247 | 1.00 | MMP2 (0.57) | MMP2MMP9PLAUHPNITGB3 | |
| Hydrochloric Acid SCHEMBL920895 | 0.99 | MMP2 (0.56) | MMP2MMP9PLAUHPNITGB3 | |
| Hydrochloric Acid SCHEMBL11406948 | 0.99 | MMP2 (0.56) | MMP2MMP9PLAUHPNITGB3 | |
| Hydrochloric Acid SCHEMBL15537019 | 0.98 | MMP2 (0.55) | MMP2MMP9PLAUHPNITGB3 | |
| SCHEMBL1305743 | 0.89 | MMP2 (0.56) | MMP2MMP9PLAUHPNITGB3 | |
| SCHEMBL1305745 | 0.89 | MMP2 (0.56) | MMP2MMP9PLAUHPNITGB3 | |
| SCHEMBL5490595 | 0.88 | PLAU (0.45) | MMP2MMP9PLAUHPNITGB3 | |
| SCHEMBL28509074 | 0.87 | MMP2 (0.60) | MMP2MMP9PLAUHPNITGB3 | |
| SCHEMBL20008635 | 0.87 | MMP9 (0.67) | MMP2MMP9ITGB3ITGA2BSLC1A3 | |
| SCHEMBL28212986 | 0.87 | MMP9 (0.67) | MMP2MMP9ITGB3ITGA2BSLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 430 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2722054-B1 | Methods and compositions for oral administration of proteins | ORAMED PHARMACEUTICALS INC (IL) | 2018-03-21 | — | — | EP | claimed |
| US-20160206703-A1 | METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS | ORAMED PHARMACEUTICALS INC. (IL) | 2016-07-21 | — | — | US | claimed |
| US-8333985-B2 | Non-glycerol stabilized bone graft | WARSAW ORTHOPEDIC, INC. (US) | 2012-12-18 | — | — | US | claimed |
| US-7914542-B2 | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions | NEOTRACT, INC. (US) | 2011-03-29 | — | — | US | claimed |
| US-20090192439-A1 | DEVICES, SYSTEMS AND METHODS FOR TREATING BENIGN PROSTATIC HYPERPLASIA AND OTHER CONDITIONS | NEOTRACT, INC. (US) | 2009-07-30 | — | — | US | claimed |
| US-20090060977-A1 | DEVICES, SYSTEMS AND METHODS FOR TREATING BENIGN PROSTATIC HYPERPLASIA AND OTHER CONDITIONS | NEOTRACT, INC. (US) | 2009-03-05 | — | — | US | claimed |
| US-20090018523-A1 | DEVICES, SYSTEMS AND METHODS FOR TREATING BENIGN PROSTATIC HYPERPLASIA AND OTHER CONDITIONS | NEOTRACT, INC. (US) | 2009-01-15 | — | — | US | claimed |
| EP-1887976-A2 | DEVICES, SYSTEMS AND METHODS FOR TREATING BENIGN PROSTATIC HYPERPLASIA AND OTHER CONDITIONS | Neotract, Inc. (US) | 2008-02-20 | — | — | EP | claimed |
| US-20070178158-A1 | Stabilized bone graft | WARSAW ORTHOPEDIC, INC. | 2007-08-02 | — | — | US | claimed |
| US-20060276871-A1 | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions | EXPLORAMED NC2, INC. (US) | 2006-12-07 | — | — | US | claimed |
| WO-2006127431-A2 | DEVICES, SYSTEMS AND METHODS FOR TREATING BENIGN PROSTATIC HYPERPLASIA AND OTHER CONDITIONS | NEOTRACT, INC. (US) | 2006-11-30 | — | — | WO | claimed |
| US-20060035827-A1 | Compositions and methods for the treatment or prevention of gallbladder disease | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2006-02-16 | — | — | US | claimed |
| US-20030143258-A1 | Bone graft | WARSAW ORTHOPEDIC, INC. | 2003-07-31 | — | — | US | claimed |
| US-12268797-B2 | Non-cultured, partially digested, cryopreserved cartilage product | OSIRIS THERAPEUTICS, INC. (US) | 2025-04-08 | — | — | US | disclosed |
| US-12201283-B2 | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions | Teleflex Life Sciences Llc (US) | 2025-01-21 | — | — | US | disclosed |
| US-12173348-B2 | Method for detecting enzymatic reaction product | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2024-12-24 | — | — | US | disclosed |
| WO-1993024634-A1 | DIPEPTIDYL PEPTIDASE-I, CLONING IT, AND THERAPEUTIC AGENTS CONTAINING INHIBITORS THEREOF | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1993-12-09 | — | — | WO | disclosed |
| US-5252463-A | Measuring protease inhibition of a protein | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1993-10-12 | — | — | US | disclosed |
| WO-1992000374-A1 | PROTEASE CLIPSIN AND METHOD OF USE | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-01-09 | — | — | WO | disclosed |
| US-5069707-A | PROTEASE INHIBITOR TO CONTROL HARVESTING TIME | AJINOMOTO CO., INC. (JP) | 1991-12-03 | — | — | US | disclosed |